跳至主要内容
临床试验/NCT04964739
NCT04964739已完成不适用

Gender and Sex Hormone Influences on Cannabis Use Disorder Remission

Medical University of South Carolina2 个研究点 分布在 1 个国家目标入组 224 人开始时间: 2021年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
224
试验地点
2
主要终点
Proportion of participants in remission

研究概览

简要总结

Adults (ages 18+) who would like to reduce their cannabis use (N=224) will be enrolled in an 8-week treatment program. All participants will receive counseling (1 goals session with a therapist followed by 7 weekly computerized cognitive-behavioral therapy sessions). Detailed cannabis assessments (biological and self-report) will be conducted throughout treatment and at 1-, 2-, and 3-months post-treatment completion. Daily electronic diaries will be administered via text message to record detailed logs of cannabis use quantity and frequency. Salivary samples will be collected (and video observed) daily throughout treatment to analyze for progesterone.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willingness to participate in a research study (otherwise, will be referred to appropriate clinical services if seeking clinical care).
  • Meet current (within last 30 days) DSM-5 criteria for cannabis use disorder.
  • Submit a positive urine cannabinoid test during screening.
  • Interested in treatment for cannabis use disorder.

排除标准

  • Significant or acutely unstable medical or psychiatric problems (i.e., psychosis, mania) that would contraindicate research procedures, interfere with safety, compromise data integrity, or preclude consistent study participation.
  • The presence of any substance use disorder requiring a higher level of care.
  • Significant risk of homicide or suicide.
  • Pregnant, trying to become pregnant, or breastfeeding.

结局指标

主要结局

Proportion of participants in remission

时间窗: Week 20

Remission is classified as the absence of DSM-5 cannabis use disorder symptoms (except cravings) as measured by semi-structured diagnostic interview.

Reduction in cannabis use days

时间窗: 8 weeks of treatment

Number of cannabis use days assessed via daily diaries during treatment

Reduction in cannabis use episodes

时间窗: 8 weeks of treatment

Number of cannabis use episodes assessed via daily diaries during treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验